LSIIF: AI 评分 47/100 — AI 分析 (4月 2026)

Lisi S.A. is a global industrial company specializing in the design and manufacture of high-value-added assembly and component solutions. The company serves the aerospace, automotive, and medical industries, operating through three distinct divisions.

Key Facts: AI Score: 47/100 Sector: Industrials

公司概况

概要：

Lisi S.A., founded in 1777, provides assembly and component solutions for the aerospace, automotive, and medical industries internationally. With a market capitalization of $2.69 billion and a P/E ratio of 16.14, Lisi operates through three divisions, focusing on high-value-added components and assemblies.

LSIIF是做什么的？

Lisi S.A., tracing its origins back to 1777, has evolved from GFI Industries into a prominent provider of assembly and component solutions. Headquartered in Belfort, France, Lisi operates globally, serving the aerospace, automotive, and medical industries. The company's structure is organized into three divisions: LISI Aerospace, LISI Automotive, and LISI Medical. LISI Aerospace provides critical components such as titanium nuts, lightning strike protection, and complex engine parts for the LEAP engine and Airbus aircraft. LISI Automotive delivers fastening and assembly solutions for automotive systems, including braking, safety, and interior components. LISI Medical focuses on designing and manufacturing implants and instruments for orthopedic and surgical applications. Lisi S.A. is a subsidiary of Compagnie Industrielle De Delle S.A.

LSIIF的投资论点是什么？

Lisi S.A. presents a compelling investment case based on its diversified exposure to the aerospace, automotive, and medical sectors. The company's focus on high-value-added components and assemblies provides a degree of resilience against economic cycles. With a market capitalization of $2.69 billion and a profit margin of 7.9%, Lisi demonstrates financial stability. Key growth catalysts include the recovery of the aerospace industry, increasing demand for advanced automotive components, and the expanding market for medical implants. Potential risks include fluctuations in raw material prices and competition from other industrial manufacturers. The company's dividend yield is 0.79%.

LSIIF在哪个行业运营？

Lisi S.A. operates in the industrial sector, specifically within the aerospace & defense, automotive, and medical industries. These sectors are characterized by high barriers to entry, stringent quality standards, and long-term contracts. The aerospace industry is experiencing a recovery, driven by increased air travel and aircraft production. The automotive industry is undergoing a transformation with the rise of electric vehicles and advanced driver-assistance systems (ADAS). The medical industry is growing due to an aging population and advancements in medical technology. Lisi competes with companies like AUTLF, CHYCY, CMGMF, CMGMY, and IRRHF.

Aerospace & Defense

Industrials

LSIIF有哪些增长机遇？

Aerospace Recovery: The resurgence of the aerospace industry, driven by increased air travel and aircraft orders, presents a significant growth opportunity for LISI Aerospace. As airlines expand their fleets and aircraft manufacturers ramp up production, demand for Lisi's aerospace components, including fasteners and structural parts, is expected to increase. This growth is supported by long-term contracts and the company's established relationships with major aerospace players. The timeline for this growth is ongoing, with a projected market size increase of 5-7% annually.
Automotive Electrification: The shift towards electric vehicles (EVs) and hybrid electric vehicles (HEVs) is creating new opportunities for LISI Automotive. The company's expertise in developing lightweight and high-strength fastening solutions is well-suited for the EV market, where weight reduction and performance are critical. Lisi can capitalize on the growing demand for EV components by expanding its product portfolio and targeting new customers in the EV supply chain. This growth is anticipated to accelerate over the next 3-5 years, with the EV market projected to grow at a CAGR of 20-30%.
Medical Device Innovation: The medical device industry is characterized by continuous innovation and technological advancements. LISI Medical can drive growth by investing in research and development to develop new and improved medical implants and instruments. The company can also expand its presence in emerging markets, where demand for medical devices is growing rapidly. This growth is expected to continue over the next decade, driven by an aging population and increasing healthcare spending. The global medical device market is projected to reach $600 billion by 2030.
Strategic Acquisitions: Lisi S.A. can pursue strategic acquisitions to expand its product portfolio, geographic reach, and technological capabilities. Acquisitions can provide access to new markets, customers, and technologies, accelerating the company's growth and strengthening its competitive position. Lisi can target companies in the aerospace, automotive, and medical industries that offer complementary products or services. The timeline for acquisitions is opportunistic, depending on market conditions and available targets. Successful acquisitions can contribute significantly to Lisi's long-term growth.
Operational Efficiency Improvements: Lisi S.A. can improve its profitability and competitiveness by implementing operational efficiency improvements across its three divisions. This includes streamlining manufacturing processes, reducing waste, and optimizing supply chain management. By improving its operational efficiency, Lisi can lower its costs, increase its margins, and enhance its customer service. The timeline for operational efficiency improvements is ongoing, with continuous efforts to identify and implement best practices. These improvements can contribute to a 1-2% increase in profit margins over the next 2-3 years.

Market Cap of $2.69B indicates substantial company size and investor confidence.
P/E ratio of 16.14 suggests the company is reasonably valued compared to its earnings.
Profit Margin of 7.9% reflects the company's ability to generate profit from its revenue.
Gross Margin of 31.6% demonstrates efficient cost management in production.
Dividend Yield of 0.79% provides a modest return to investors.

LSIIF提供哪些产品和服务？

Designs and manufactures assembly and component solutions.
Serves the aerospace industry with titanium nuts, lightning strike protection, and engine components.
Provides fastening and assembly solutions for the automotive industry.
Offers medical implants and instruments for orthopedic and surgical applications.
Engages in designing and modeling, prototypes, and pre-series production.
Provides solutions for weight reduction and optimizing assemblies in the automotive sector.
Offers spinal and trauma implants, such as connectors, screws, cages, and plates for medical use.

LSIIF如何赚钱？

Manufacturing and selling high-value-added components and assemblies to aerospace, automotive, and medical industries.
Providing customized solutions tailored to specific customer needs.
Generating revenue through long-term contracts and recurring orders.
Investing in research and development to develop new and innovative products.

Aerospace companies: Airbus, Boeing, and other aircraft manufacturers.
Automotive companies: Major automotive OEMs and suppliers.
Medical device companies: Hospitals, clinics, and surgeons.

High barriers to entry due to stringent quality standards and regulatory requirements.
Established relationships with major customers in the aerospace, automotive, and medical industries.
Proprietary technology and expertise in designing and manufacturing high-value-added components.
Diversified exposure to multiple industries, reducing reliance on any single sector.

什么因素可能推动LSIIF股价上涨？

Upcoming: Recovery in the aerospace industry leading to increased demand for LISI Aerospace components.
Ongoing: Automotive electrification driving demand for LISI Automotive's lightweight fastening solutions.
Ongoing: Innovation in medical devices boosting demand for LISI Medical's implants and instruments.
Upcoming: Potential strategic acquisitions to expand product portfolio and geographic reach.
Ongoing: Operational efficiency improvements to enhance profitability and competitiveness.

LSIIF的主要风险是什么？

Potential: Economic downturn impacting demand in the aerospace, automotive, and medical industries.
Potential: Fluctuations in raw material prices increasing production costs.
Potential: Increased competition from other industrial manufacturers.
Ongoing: Regulatory changes affecting the aerospace, automotive, and medical industries.
Ongoing: OTC market trading can impact liquidity and increase volatility.

LSIIF的核心优势是什么？

Diversified exposure to aerospace, automotive, and medical industries.
Established relationships with major customers.
Proprietary technology and expertise.
Strong financial performance.

LSIIF的劣势是什么？

Exposure to cyclical industries.
Reliance on raw material prices.
Competition from other industrial manufacturers.
OTC market trading can impact liquidity.

LSIIF有哪些机遇？

Aerospace recovery.
Automotive electrification.
Medical device innovation.
Strategic acquisitions.

LSIIF面临哪些威胁？

Economic downturn.
Fluctuations in raw material prices.
Increased competition.
Regulatory changes.

LSIIF的竞争对手是谁？

অটোলাইভ — Focuses on automotive safety systems. — (AUTLF)
কেএইচ কর্পোরেশন — Specializes in automotive components. — (CHYCY)
কমিউনিকেশন এন্ড পাওয়ার ইন্ডাস্ট্রিজ — Provides microwave and RF solutions. — (CMGMF)
কমিউনিকেশন এন্ড পাওয়ার ইন্ডাস্ট্রিজ — Offers communication and power solutions. — (CMGMY)
ইটোকা রিকি কর্পোরেশন — Manufactures automotive parts. — (IRRHF)

Key Metrics

MoonshotScore: 47/100

Company Profile

CEO: Emmanuel Viellard
Headquarters: Belfort, FR
Employees: 10,167
Founded: 2013

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Lisi S.A. do?

Lisi S.A. is a global industrial company that designs, manufactures, and sells high-value-added assembly and component solutions for the aerospace, automotive, and medical industries. The company operates through three divisions: LISI Aerospace, which provides critical components for aircraft; LISI Automotive, which offers fastening and assembly solutions for automotive systems; and LISI Medical, which focuses on designing and manufacturing implants and instruments for orthopedic and surgical applications. Lisi's products are used in a wide range of applications, from aircraft engines to automotive safety systems to medical implants.

What do analysts say about LSIIF stock?

AI analysis is pending for LSIIF. Therefore, a summary of analyst consensus, key valuation metrics, and growth considerations cannot be provided at this time. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions. Further information is needed to complete this section.

What are the main risks for LSIIF?

Lisi S.A. faces several risks, including exposure to cyclical industries, fluctuations in raw material prices, increased competition, regulatory changes, and OTC market trading. A downturn in the aerospace, automotive, or medical industries could negatively impact demand for Lisi's products. Fluctuations in raw material prices, such as titanium and steel, could increase production costs. Increased competition from other industrial manufacturers could erode Lisi's market share. Regulatory changes in the aerospace, automotive, and medical industries could increase compliance costs. OTC market trading can impact liquidity and increase volatility.